Picafibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12L83YI68T. European Medicines Agency schedules Picafibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09806MIG. Picafibrate generally arises in the molecular formula C18H19CLN2O4. The term PICAFIBRATE is an International Non-Proprietary Name or INN. PICAFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule picafibrate under HS 29333999 and SITC 51574. As of Q4 2014, PICAFIBRATE remains the US FDA Preferred Term for this commodity. Picafibrate bears US NLM identifiers UMLS ID C0071029 and NCI Concept Code C72993. SMILES: Clc1ccc(OC(C)(C)C(=O)OCCNC(=O)c2cccnc2)cc1.